Speakers

Prof. Antonino Spinelli MD PhD FASCRS leads the Unit of Colon and Rectal Surgery and is Associate Professor of Surgery at Humanitas University.
He dedicates to the development of innovative techniques in minimally invasive colorectal surgery.
He is Associate Editor for Colorectal Disease, Diseases of the Colon and Rectum, JARC, and Editorial Board Member for the Journal of Crohn’s Colitis and for Coloproctology.
He is Member of the Scientific Programme Committee of ESCP, Assistant Secretary of ESCP, Member of IOIBD and of ISFGS.
He is Honorary Fellow of the Czech Society of Surgery and Honorary Member of the Brazilian College of Digestive Surgery.
He authored/co-authored more than 120 Pubmed indexed papers, with an IF > 450 and an H Index of 33.

Bruce Jaffray is a paediatric surgeon in Newcastle with an interest in surgery for inflammatory bowel disease in children, and minimally invasive pouch surgery in particular. He has published on the subjects of complications of pouch surgery, the use of minimally invasive pouch surgery and survival after anti-reflux surgery among other areas in children’s surgery. His topic for today will be safe minimally invasive surgery for ulcerative colitis and Crohn’s disease in children.

Chris Lamb graduated from medical school at Newcastle University with Distinction in 2004. He undertook higher specialist training in Gastroenterology and Internal Medicine in the North East.

Chris treats a broad range of gastroenterology conditions and has a specialist interest in inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis). Chris is the lead author of the British Society of Gastroenterology national guidelines for the management of IBD. He is an investigator for several national and international clinical trials. Chris is a previous recipient of the British Society of Gastroenterology ‘Young Gastroenterologist of the Year: Emerging Leader’ award and was a recipient of the President’s Medal.

Chris leads a research programme in the Translational & Clinical Research Institute at Newcastle University. His research focuses on the intestinal immune system, how this maintains health or can drive inflammation, and how our immune system interacts with, and is shaped by intestinal microbes (bacteria, viruses and fungi). During Chris’ research training he was awarded funding from the Wellcome Trust to undertake a Master’s Degree and PhD in Translational Medicine and Therapeutics, and was subsequently awarded a 4-year National Institute for Health Research (NIHR) Academic Clinical Lecturership completed in 2019. He is the Chief Investigator for the national IBD-RESPONSE and CD-metaRESPONSE studies funded by the Medical Research Council and Helmsley Charitable Trust.

More details of Chris’ research are available here: https://www.ncl.ac.uk/medical-sciences/people/profile/christopherlamb.html

Mr Dominic Slade is a Consultant colorectal and intestinal failure surgeon at Salford Royal NHS Foundation Trust, Manchester, UK.
He graduated from Birmingham University in 1992, and undertook his surgical training in Manchester and the North West. He was appointed to his present post in 2006, where he works as a general, colorectal and intestinal failure surgeon with interests in laparoscopy, inflammatory bowel disease, intestinal failure, complex abdominal wall reconstruction and emergency general surgery. With his four surgical colleagues he offers reconstructive surgery for inflammatory bowel disease and intestinal failure resulting especially from surgical misadventure. This includes combined gastrointestinal and abdominal wall reconstruction for patients with enterocutaneous fistulas.

Professor Gabriela Möslein MD PhD EBSQ (Coloproctology) leads the Surgical Center for Hereditary Tumors and Prophylactic Surgery of the Ev. Bethesda Khs. Duisburg, Academic Hospital of the University of Düsseldorf. She is a specialized visceral surgeon and is dedicated to hereditary predisposition to GI cancers and prophylactic surgery.

She trained at the University of Heidelberg and Düsseldorf, spent 6 months working with Prof. Joji Utsunomiya in Japan and also undertook a full time research year at the Dept of Molecular Genetics (Steve Thibodeau) Mayo Clinic Rochester. She is associate editor for Familial Cancer and Hereditary Cancer in Clinical Practice.

She is current General Secretary of the ESCP, Chair of the EHTG (European Hereditary Tumor Group) and has initiated and is in the advisory board of several patient support groups. Further she has initated an ESC course on continent ileostomies – a procedure that is experiencing a true revival and this will be the topic of her presentation on this day.

Gordon Carlson is Consultant Colorectal and Intestinal Failure (IF) Surgeon at Salford Royal Hospital and Honorary Professor of Surgery at the University of Manchester. He is lead surgeon at the National IF Centre in Salford. He trained in Manchester and Newcastle, but has held numerous visiting appointments in Scandinavia, where he has been involved in the development of IF services, as well as in North America and Canada. He has published 200 papers and book chapters and was previously national advisor on surgery for IF at NHS England. He represents the RCS on the NHS Cross Systems Sepsis Board and is very proud to have been invited to take over the Presidency of IA this year.

James Kinross is a Senior Lecturer in Colorectal Surgery and a Consultant Surgeon at Imperial College London. His clinical interest is in minimally invasive and robotic surgery for colorectal cancer. He was a National Institute for Health Research (NIHR) Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD on the gut microbiome and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland and at the African Microbiome Institute. His group is studying how the gut microbiome causes IBD and colorectal cancer and how it may be engineered to improve operative outcomes.

Laura is a Consultant Colorectal Surgeon at Manchester University NHS Foundation Trust and Honorary Senior Clinical Lecturer at the University of Manchester. She is the ACPGBI Chair of Education and Training and a member of the ACPGBI IBD sub-committee. She is a member of the UK IBD Genetics Consortium and the HDR-UK IBD Hub (Gut Reaction) Programme Board. She was awarded the Royal College of Surgeons of England IBD Research Fellowship in Oxford investigating clinical and molecular characteristics of Crohn’s disease, supported by the IA and the IOIBD. Her clinical and research interests are dedicated to improving outcomes for people with IBD.

University of Edinburgh Professor and Group Leader in MRC Human Genetics Unit. Since 2000, Chair of Coloproctology and Academic Head of the Colorectal Surgery Unit, Western General Hospital. Active laboratory research program focused around understanding the genetic architecture of colorectal cancer risk. He aims to define the functional consequences and intervene with beneficial effect on survival and/or prevention through gene discovery in human populations and genetic manipulations in model systems. Clinical work focused on cancer and inflammatory bowel disease. The Department is one of the highest volume centres in the UK. The Edinburgh pouch database has ~1000 patients with long term follow up. MGD contributed as member/author of the 2020 BSG IBD guidelines group.

Consultant Gastroenterologist in Newcastle Trust Hospitals for 15 years. Specialist interests IBD, small bowel diseases, anaemia and GI bleeding. I sub-specialize in IBD in the pregnant patients, running a combined service over the last 4 years with a consultant Obstetric Colleague.

Graduated from the Karolinska Institute. Trained in surgery and colorectal surgery at Linköping University Hospital. PhD thesis on immunomodualtion an surgery in Crohn’s disease. Post doc and clinical IBD fellow in Oxford. Previous head of the colorectal unit in Linköping and previous memeber of the board of the Swedish Society of Gastroenterolgy and previous president of the Swedish Society of Colorectal Surgery. Member of the S-ECCO board and president of the Swedish Organisation of IBD studies (SOIBD) and the Swedish IBD Register (SWIBREG).

Phil leads the Fistula Research Unit at St Mark’s and has clinical and research interests in anal, rectovaginal, pouch, IBD-related and anastomotic fistula. His work includes complex IBD and post disaster surgery including deep pelvic sepsis and chronic anastomotic failure. He has published widely in anal fistula, particularly in Crohn’s disease.

Professor Coffey is Foundation Chair and Professor of Surgery, Head of Department of Surgery, at the University of Limerick Hospital Group, Limerick, Ireland.  His group has characterised the development and shape of the human mesentery and their work has led to reclassification of the mesentery as an organ (t.co/4aeJtc3LSG).  His group pioneered the introduction of robotic colorectal surgery in Ireland, as well as mesenteric-based approaches to surgery for Crohn’s disease and congenital abnormalities such as malrotation.  He is senior author of Mesenteric Based Principles of Gastrointestinal Surgery: Basic and applied Principles (http://ow.ly/Y4Db30ar60z).

Professor of Surgery University of Sheffield. Interests in IBD surgery.

I am a laparoscopic and colorectal consultant surgeon and colorectal service lead at North Tees and Hartlepool NHS Trust and has been working at University Hospital of North Tees since 2007. I am also Honorary lecturer at Teesside University, Middlesbrough. I am member of Education & Training committee of ACPGBI. I have special interests in advanced laparoscopic including single incision laparoscopic colorectal surgery, inflammatory bowel disease, early rectal cancer and surgical training. I have published various articles and written book chapters in my areas of interests.

Tom is the George Drexler & Royal College of Surgeons Chair of Surgical Trials and the University of Birmingham and an Honorary Consultant Colorectal Surgeon at University Hospitals Birmingham NHSFT. He is Director of the Birmingham Surgical Trials Consortium and sits on the NIHR Health Technology Assessment (HTA) Clinical Evaluation and Trials Board and the NIHR Research for Patient Benefit (RfPB) West Midlands Panel. Research interests are predominantly in clinical and translational research in inflammatory bowel disease and surgical site infection.

I am a coal face GI Radiologist specialising in IBD, colorectal and acute imaging. I enjoy opportunistic targeted ultrasound, low dose CT and team supported decision making. Imaging is great and your friendly radiology colleagues can make your life easier.